- Home
- EXAS vs APPF Comparison
EXAS vs APPF Comparison
Compare EXAS & APPF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EXAS
- APPF
- Stock Information
- Founded
- EXAS 1995
- APPF 2006
- Country
- EXAS United States
- APPF United States
- Employees
- EXAS N/A
- APPF N/A
- Industry
- EXAS Medical Specialities
- APPF Computer Software: Prepackaged Software
- Sector
- EXAS Health Care
- APPF Technology
- Exchange
- EXAS Nasdaq
- APPF Nasdaq
- Market Cap
- EXAS 8.8B
- APPF 7.8B
- IPO Year
- EXAS N/A
- APPF 2015
- Fundamental
- Price
- EXAS $43.06
- APPF $218.43
- Analyst Decision
- EXAS Strong Buy
- APPF Buy
- Analyst Count
- EXAS 18
- APPF 6
- Target Price
- EXAS $70.59
- APPF $279.83
- AVG Volume (30 Days)
- EXAS 2.0M
- APPF 328.4K
- Earning Date
- EXAS 05-07-2025
- APPF 04-24-2025
- Dividend Yield
- EXAS N/A
- APPF N/A
- EPS Growth
- EXAS N/A
- APPF 7828.57
- EPS
- EXAS N/A
- APPF 5.55
- Revenue
- EXAS $2,758,867,000.00
- APPF $794,202,000.00
- Revenue This Year
- EXAS $13.02
- APPF $20.42
- Revenue Next Year
- EXAS $13.02
- APPF $17.31
- P/E Ratio
- EXAS N/A
- APPF $39.87
- Revenue Growth
- EXAS 10.37
- APPF 28.00
- 52 Week Low
- EXAS $40.62
- APPF $189.01
- 52 Week High
- EXAS $79.62
- APPF $274.56
- Technical
- Relative Strength Index (RSI)
- EXAS 36.15
- APPF 44.76
- Support Level
- EXAS $44.00
- APPF $212.02
- Resistance Level
- EXAS $47.23
- APPF $230.52
- Average True Range (ATR)
- EXAS 1.57
- APPF 6.37
- MACD
- EXAS 0.06
- APPF 1.07
- Stochastic Oscillator
- EXAS 15.86
- APPF 41.37
About EXAS Exact Sciences Corporation
Exact Sciences Corporation, headquartered in Madison, Wisconsin, provides cancer screening and diagnostic test products in the United States and internationally. Exact's Cologuard screening test, a noninvasive stool-based DNA test, is a pre-cancer screening test for colorectal cancer. The company also competes in the precision oncology market with Oncotype DX, a suite of tissue-based genomic tests for estimating recurrence risk and likelihood of benefit from chemotherapy for breast and colon cancer, and OncoExTra, a liquid-based comprehensive genomic profiling test. It is developing liquid biopsy tests for molecular residual disease, colorectal cancer screening, and multicancer screening, too.
About APPF AppFolio Inc.
AppFolio Inc is a provider of cloud-based software solutions for real estate industry. Its property management software provides property managers with an end-to-end solution to their business needs. Its products include cloud-based property management software (Appfolio Property Manager). It also offers value-added services, such as screening, risk mitigation and electronic payment services. The business activity of the firm predominantly functions through the United States and it generates revenue in the form of subscription fees.